AstraZeneca Pharma India Limited — Others, 13-06-2025: Disclosure under SEBI Takeover Regulations

The company has announced a board meeting to consider and approve the financial results for the quarter and half-year. This reflects progress in its financial reporting and ensures timely updates for investors to assess recent operational performance. No changes in auditor, shareholding, or other operational matters have been reported, keeping the focus on the upcoming financial disclosures.